Biogen Idec R&D Boss Retires

Luke Timmerman3/12/09

Biogen Idec said today that its president of R&D, Cecil Pickett, is retiring. Pickett, 62, will stay in the job until a replacement is filled, and he will keep his seat on the board of directors after retirement, the company said in a regulatory filing. Pickett joined the Cambridge, MA-based biotech company (NASDAQ: BIIB) in September 2006 from Kenilworth, NJ-based Schering-Plough. Biogen didn’t say when it expects to name its new R&D leader.

Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.